Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner
Open Access
- 21 September 2023
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (12) , 4801-4822
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (2021A1515012456)
- National Natural Science Foundation of China (82171877)
This publication has 77 references indexed in Scilit:
- Methamphetamine Psychosis: Epidemiology and ManagementCNS Drugs, 2014
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depressionProgress in Neurobiology, 2013
- The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in MiceGastroenterology, 2011
- Normal gut microbiota modulates brain development and behaviorProceedings of the National Academy of Sciences, 2011
- Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsideredHuman Psychopharmacology: Clinical and Experimental, 2010
- GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in ColonCancer Research, 2009
- Methamphetamine abuse and impairment of social functioning: A review of the underlying neurophysiological causes and behavioral implications.Psychological Bulletin, 2008
- New insights into BDNF function in depression and anxietyNature Neuroscience, 2007
- Pilot Study: Fluvoxamine Treatment for Depression and Anxiety Disorders in Children and Adolescents with CancerJournal of the American Academy of Child & Adolescent Psychiatry, 2005